Cargando…
ARE THE OPTIMUM PHARMACEUTICAL PREPARATIONS USED FOR THE SECOND-LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION IN JAPAN? - A DISCUSSION FROM A SIMULATION FOR THE AMOUNT OF ANTIBIOTICS IN STOMACH BASED ON THE DATA OF DISSOLUTION STUDIES -
The purpose of this study was to evaluate whether the optimum preparations are used for the second-line eradication therapy for Helicobacter pylori (H. pylori) infection in Japan. In the therapy, commercial tablets, which have 250 mg of amoxicillin (AMX) and 250 mg of metronidazole (MTZ), are used a...
Autores principales: | Kubodera, Mai, Tokumura, Tadakazu, Machida, Yoshiharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979214/ https://www.ncbi.nlm.nih.gov/pubmed/24825995 |
Ejemplares similares
-
Determination of metronidazole in a rat stomach by HPLC for obtaining basic data of the eradication therapy of Helicobacter pylori
por: Kubodera, Mai, et al.
Publicado: (2012) -
Vonoprazan-Associated Gastric Mucosal Redness in Non-Helicobacter pylori-Infected and Helicobacter pylori-Eradicated Stomach
por: Kubo, Kimitoshi, et al.
Publicado: (2021) -
Prevention of gastric cancer by Helicobacter pylori eradication: A review from Japan
por: Uno, Yoshiharu
Publicado: (2019) -
“Latent Gastric Cancer” after Eradicating Helicobacter pylori
por: Uno, Yoshiharu
Publicado: (2018) -
Adequate amounts of probiotics increase the success rate of Helicobacter pylori eradication therapy in children
por: Kakiuchi, Toshihiko
Publicado: (2023)